Rick Gon­za­lez de­fend­ed Ab­b­Vie's em­pire. The next CEO will have to build a new one be­yond Hu­mi­ra

As Ab­b­Vie’s CEO, Rick Gon­za­lez took Hu­mi­ra from a megablock­buster in­to some­thing sin­gu­lar: a pol­i­tics- and com­pe­ti­tion-de­fy­ing prod­uct that be­came the best-sell­ing drug of all time.

In his fi­nal act, he has pre­pared Ab­b­Vie for life af­ter its sig­na­ture prod­uct. When Gon­za­lez re­tires as CEO in Ju­ly, he’ll hand the top spot to Robert Michael, Ab­b­Vie’s pres­i­dent and chief op­er­at­ing of­fi­cer, who will in­her­it a high-fly­ing stock and two new ma­jor deals meant to set up Ab­b­Vie for the fu­ture.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER